ClinicalTrials.gg
Not yet recruitingNCT06389253Updated May 1, 2024

Subtalar Extra-articular Screw Arthroereisis

An observational study in Flatfoot, Flexible, sponsored by Università Vita-Salute San Raffaele. Not yet recruiting at 2 sites in Italy. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-01.

Sponsored by Università Vita-Salute San Raffaele · Observational

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
40
Ages
10 Years and older
Sex
All
01

Study summary

The aim of the study is to investigate the effect of subtalar extra-articular calcaneo-stop screw on the proprioceptive and nociceptive pathways of the ankle before and after implantation. The hypothesis of the study is that an increased number of receptors related to proprioception will be detected in the sinus tarsi.

02

Conditions studied

  • Flatfoot, Flexible

Browse trials for

03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

This study's planned enrollment of 40 is below the median of 47 across 48 observational studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Università Vita-Salute San Raffaele is the lead sponsor of 85 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with subtalar extraarticular screw arthroereisis, gender male and female, no comorbidities.

Control group are patients that will insert the calcaneo-stop screw (age between 10 and 14 years old).

Study group are patient that remove the calcaneo-stop screw (age from 14 years old)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Study Group:

  • Patients aged 14 years old and above that will remove the calcaneo stop screw, in place for at least 3 years after the implant, will be recruited
  • Patients willing and able to give for the participation in the study. For underage patients, a parent/legal representative will give consent for the participation in the study.
  • Male and female patients in fertile age can be recruited.

Control Group:

  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.

Exclusion criteria

Exclusion Criteria:

Control Group:

  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.

Study Group:

  • Patients suffering from post-operative complications
  • Syndromic patients
  • Previous foot malformation (synostosis, congenital clubfoot)
  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control Group

    Control group are patients that will insert the calcaneo-stop screw (age between 10 and 14 years old).

    Other: Histological Analysis

  • Study Group

    Study group are patient that remove the calcaneo-stop screw (age from 14 years old)

    Other: Histological Analysis

Interventions

  • OtherHistological Analysis

    For the study, a minimal part of the periarticular tissue, specifically the sinus tarsi juxta-articular fatty tissue, that is normally dissected and discarded during the surgical operation of insertion and removal of the calcaneo-stop screw, will be analyzed

06

What researchers measure

Primary outcomes

  1. Primary Endpoint (%)

    Percentage of patients presenting at least one proprioceptive fibers in the pericapsular tissue

    Time frame: Time 0 (baseline)

Secondary outcomes

  1. Secondary Endpoint

    Number and type of nervous fibers

    Time frame: Time 0 (baseline)

07

Study locations

2 sites
08

References and documents

Publications

  • De Pellegrin M, Moharamzadeh D. Subtalar Arthroereisis for Surgical Treatment of Flexible Flatfoot. Foot Ankle Clin. 2021 Dec;26(4):765-805. doi: 10.1016/j.fcl.2021.07.007. Epub 2021 Oct 4. PubMed 34752238 ↗
  • Michaudet C, Edenfield KM, Nicolette GW, Carek PJ. Foot and Ankle Conditions: Pes Planus. FP Essent. 2018 Feb;465:18-23. PubMed 29381041 ↗
  • Mosca VS. Flexible flatfoot in children and adolescents. J Child Orthop. 2010 Apr;4(2):107-21. doi: 10.1007/s11832-010-0239-9. Epub 2010 Feb 18. PubMed 21455468 ↗
  • Harris EJ. The natural history and pathophysiology of flexible flatfoot. Clin Podiatr Med Surg. 2010 Jan;27(1):1-23. doi: 10.1016/j.cpm.2009.09.002. PubMed 19963167 ↗
  • Jane MacKenzie A, Rome K, Evans AM. The efficacy of nonsurgical interventions for pediatric flexible flat foot: a critical review. J Pediatr Orthop. 2012 Dec;32(8):830-4. doi: 10.1097/BPO.0b013e3182648c95. PubMed 23147627 ↗
  • De Pellegrin M, Moharamzadeh D, Strobl WM, Biedermann R, Tschauner C, Wirth T. Subtalar extra-articular screw arthroereisis (SESA) for the treatment of flexible flatfoot in children. J Child Orthop. 2014 Dec;8(6):479-87. doi: 10.1007/s11832-014-0619-7. Epub 2014 Nov 21. PubMed 25413354 ↗
  • Rein S, Manthey S, Zwipp H, Witt A. Distribution of sensory nerve endings around the human sinus tarsi: a cadaver study. J Anat. 2014 Apr;224(4):499-508. doi: 10.1111/joa.12157. Epub 2014 Jan 29. PubMed 24472004 ↗
  • Freeman MA, Wyke B. The innervation of the knee joint. An anatomical and histological study in the cat. J Anat. 1967 Jun;101(Pt 3):505-32. No abstract available. PubMed 6051731 ↗
  • Hagert E, Forsgren S, Ljung BO. Differences in the presence of mechanoreceptors and nerve structures between wrist ligaments may imply differential roles in wrist stabilization. J Orthop Res. 2005 Jul;23(4):757-63. doi: 10.1016/j.orthres.2005.01.011. Epub 2005 Mar 29. PubMed 16022987 ↗
  • Hagert E. Proprioception of the wrist joint: a review of current concepts and possible implications on the rehabilitation of the wrist. J Hand Ther. 2010 Jan-Mar;23(1):2-17. doi: 10.1016/j.jht.2009.09.008. Epub 2009 Dec 5. PubMed 19963343 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2024; primary completion for May 2025, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2024
First posted
Apr 29, 2024
StartEst.
May 2024
Primary completionEst.
May 2025
CompletionEst.
May 2025
Last update
May 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06389253
Lead sponsor
Università Vita-Salute San Raffaele
Responsible party
Professor Giacomo Placella (Professor, Università Vita-Salute San Raffaele) — Principal investigator
First posted
Apr 29, 2024
Start date
May 2024 (estimated)
Primary completion
May 2025 (estimated)
Completion
May 2025 (estimated)
Last update
May 1, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion